1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow ASC Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD) ASC930 - Acute-graft-versus-host Disease | Phase 2 | Unknown | ASC Therapeutics | 60 | 2023-12-01 | 2023-07-20 |
| ASC618 Gene Therapy in Hemophilia A Patients ASC618 - Hemophilia A | Phase 1 / Phase 2 | Recruiting | ASC Therapeutics | 12 | 2022-08-03 | 2023-02-01 |
Hemophilia A (1)
United States (1)